Basij Commander Praises Iran's Progress in Science, Technology.
Addressing a students gathering in Iran's Northwestern province of Khorassan Razavi on Saturday, the General appreciated the high morale and the hardworking spirit of Basiji students and professors, and asked them to further bolster their fields of activity.
He said enemy states are angry with Iran's eye-catching progress in different fields, specially in hi-tech, and have resorted to various means, including assassination of Iran's renowned scientists and elites, to stop the country's progress.
The commander further stated that the momentum of Iran's scientific progress grows faster each day, and added, "We have overtaken the arrogant states (i.e. the US and its western allies) in many branches of science and are ahead of them in many scientific fields at present."
In recent years, Iran has taken a wide stride in many fields of science and technology.
In a most recent case, Iranian Health Minister Marziyeh Vahid Dastjerdi announced earlier today that the country would soon start production of 15 types of anti-cancer drugs.
"15 types of monoclonal anti-body drugs are being synthesized with the help of the Scientific Department of the Presidential Office, using hi-tech technology," Vahid Dastjerdi said.
Noting that these anti-cancer drugs are now produced by only two to three western companies, she raised the possibility that the Iran-made monoclonal antibodies would be introduced to the Iranian market within the next two months.
Monoclonal antibody drugs are a relatively new innovation in cancer treatment. While several monoclonal antibody drugs are available for treating certain cancers, the best way to use these new drugs isn't always clear.
Also earlier this year, Iranian scientists succeeded in producing new types of medication for treating different kinds of cancer, viral diseases and arthritis with 100% positive results.
"The medicine has been synthesized through a new and unique formula and has the capability to destroy all malignant cancerous cells," Head of the research team Qassem Tak Dehqan told reporters in April.
In January, the Atomic Energy Organization of Iran (AEOI) announced that Iranian scientists have managed to synthesize two new types of radiomedicines to treat malignant types of cancer.
"The Iranian scientists and researchers of the AEOI's Nuclear Science and Technology Research Center succeeded in producing two new radiomedicines for the first time to cure malignant cancers," AEOI Spokesman Hamid Khadem Qaemi said at the time.
He named the radiomedicines as Lutetium-177 Phosponate (EDTMP) for bone pain palliation in metastatic prostate cancer and Iodine 131 Chlorotoxin to treat malignant glioma.
Also, Iran in December unveiled five different radiomedicine projects with applications for diagnosis, prevention and treatment of a number of diseases.
In September 2010, Iran announced that it plans to synthesize 20 kinds of radiomedicine inside the country.
"Iran has gained the necessary preparedness to produce 20 radiomedicines and we will provide the 20% (enriched nuclear) fuel needed for the production of these medicines this year," AEOI Deputy Head for Planning, International and Parliamentary Affairs Massoud Akhavan-Fard told FNA at the time.
In addition to the Tehran research reactor which has long been used by radioisotope production, Iran also plans to build four other research reactors in the other parts of the country, he added.
2011 Fars News Agency. All rights reserved
Provided by Syndigate.info an Albawaba.com company
|Printer friendly Cite/link Email Feedback|
|Publication:||FARS News Agency|
|Date:||Sep 3, 2011|
|Previous Article:||Scientists Find Stem Cells That Tell Hair to Grow.|
|Next Article:||Police Seize 3 Drug Cargos in Northeastern Province.|